Reaven, Gerald M <br/><br/>
HOMA-beta in the UKPDS and ADOPT. Is the natural history of type 2 diabetes characterised by a progressive and inexorable loss of insulin secretory function? Maybe? Maybe not?  [electronic resource] 

 -  Diabetes & vascular disease research  Apr 2009 
 - 133-8 p.  digital 
<br/><br/> Publication Type: Journal Article; Review 
<br/><br/><label>ISSN: </label>1752-8984 
<br/><br/><label>Standard No.: </label>10.1177/1479164109336038  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Biomarkers--blood<br/>Blood Glucose--metabolism<br/>Clinical Trials as Topic<br/>Diabetes Mellitus, Type 2--blood<br/>Disease Progression<br/>Evidence-Based Medicine<br/>Fasting--blood<br/>Humans<br/>Hypoglycemic Agents--therapeutic use<br/>Insulin--blood<br/>Insulin Secretion<br/>Insulin-Secreting Cells--drug effects<br/>Models, Biological<br/>Predictive Value of Tests<br/>Time Factors<br/>Treatment Outcome